The Rosiglitazone Story — Lessons from an FDA Advisory Committee Meeting
C. J. Rosen
- 8 Aug, 2007
This article requires a subscription.
Login via Athens or your institution
Already a print subscriber? Activate your online access
Not a Subscriber?
